Aliyu, Muktar H.
Wudil, Usman J.
Ingles, Donna J.
Shepherd, Bryan E.
Gong, Wu
Musa, Baba M.
Muhammad, Hamza
Sani, Mahmoud U.
Abdu, Aliyu
Nalado, Aisha M.
Atanda, Akinfenwa
Ahonkhai, Aima A.
Ikizler, Talat A.
Winkler, Cheryl A.
Kopp, Jeffrey B.
Kimmel, Paul L.
Wester, C. William http://orcid.org/0000-0002-8375-3926
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK12271)
Article History
Received: 26 March 2019
Accepted: 13 May 2019
First Online: 10 June 2019
Ethics approval and consent to participate
: Research and regulatory approvals have been obtained from the AKTH Ethics Committee (FWA00026225), the Institutional Review Board of Vanderbilt University (FWA00005756; IRB# 172089), the U.S. Food and Drug Administration (deemed exempt; Reference ID: 4166648), and the Nigeria National Agency for Food and Drug Administration and Control. The authors also confirm that informed consent will be obtained from all study participants in this clinical trial.
: Not applicable.
: The authors declare that they have no competing interests.